Septalyst Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.23 M
- Company Age 14 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 10.49 Cr
- Revenue Growth 27.97%
- Profit Growth 22.02%
- Ebitda -62.17%
- Net Worth 4.08%
- Total Assets 18.67%
About Septalyst Lifesciences
Septalyst Lifesciences Private Limited (SLPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 10 June 2010 and has a history of 14 years and eight months. Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.23 M.
The company currently has active open charges totaling ₹10.49 Cr.
Yogesh Sharma, Ajeet Singh, Bhaskar Mamgai, and Two other members serve as directors at the Company.
Company Details
- Location
Thane, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U74900MH2010PTC203994
- Company No.
203994
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Jun 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Septalyst Lifesciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shyam Singh  | Managing Director | 10-Jun-2010 | Current |
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vishal Bohidar | Director | 10-Jun-2010 | Current |
| Yogesh Sharma | Director | 10-Jun-2010 | Current |
| Ajeet Singh | Director | 26-Oct-2021 | Current |
| Bhaskar Mamgai | Director | 26-Oct-2021 | Current |
Financial Performance of Septalyst Lifesciences.
Septalyst Lifesciences Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 27.97% increase. The company also saw a substantial improvement in profitability, with a 22.02% increase in profit. The company's net worth moved up by a moderate rise of 4.08%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Septalyst Lifesciences?
In 2021, Septalyst Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹104.86 M
₹0
Charges Breakdown by Lending Institutions
- Others : 8.95 Cr
- Hdfc Bank Limited : 1.54 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Jul 2022 | Others | ₹6.50 Cr | Open |
| 27 Jul 2022 | Others | ₹2.45 Cr | Open |
| 08 Feb 2021 | Hdfc Bank Limited | ₹4.31 M | Open |
| 28 Jan 2021 | Hdfc Bank Limited | ₹1.11 Cr | Open |
How Many Employees Work at Septalyst Lifesciences?
Septalyst Lifesciences has a workforce of 131 employees as of Dec 16, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Septalyst Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Septalyst Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
